CEI
SPPI

Clark Estates Inc’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Clark Estates Inc’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-230,000
Closed -$2.04M – 134
2013
Q4 		$2.04M Hold
230,000
– – 0.29% 73
2013
Q3 		$1.93M Hold
230,000
– – 0.29% 72
2013
Q2 		$1.72M Buy
+230,000
New +$1.76M 0.3% 67

Other funds holding SPPI

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clark Estates Inc's SPPI Position: Q1 2014 in Review

Clark Estates Inc sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2014, closing a stake of 230,000 shares — an estimated $2.04M sold.

Clark Estates Inc first reported a position in SPPI in Q2 2013 and held it in 3 quarters. The position peaked at $2.04M in Q4 2013. 119 funds tracked by Wall St. Rank hold SPPI as of Q1 2014.

  • Clark Estates Inc reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Clark Estates Inc sold 230,000 Spectrum Pharmaceuticals Inc shares in Q1 2014, an estimated $2.04M.
  • Clark Estates Inc first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Clark Estates Inc's Spectrum Pharmaceuticals Inc position peaked at $2.04M in Q4 2013.
  • 119 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2014.

Based on Clark Estates Inc's 13F filing for Q1 2014, filed 30 Apr 2014.